1. Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion;Grover;Can. J. Physiol. Pharmacol.,1997
2. Therapeutic potential of potassium channel activators in coronary heart disease;Haeusler;Eur. Heart J.,1994
3. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin;Borg;J. Pharmacol. Exp. Ther.,1991
4. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery;Liu;Ann. Thorac. Surg.,2001
5. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen;Magnon;J. Pharmacol. Exp. Ther.,1994